Mallinckrodt announced that the FDA has approved Gablofen (baclofen injection) prefilled syringes. Gablofen prefilled syringe was created to reduce preparation steps and simplify the pump refill process for patients receiving ITB Therapy (intrathecal baclofen therapy). Gablofen is a central muscle relaxant indicated to treat severe spasticity of cerebral and spinal origin.
A refill convenience kit has been re-designed to include what is needed for pump refills using Gablofen prefilled syringes.
Gablofen prefilled syringes will be available in February 2013. Gablofen is currently available in ready-to-use vials in 50mcg/mL (screening dose), 500mcg/mL, 1000mcg/mL, and 2000mcg/mL strengths.
For more information call (888) 744-1414 or visit www.gablofen.com